High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
One Stop Systems (NASDAQ:OSS) reported second-quarter 2026 revenue growth of 62.3% from continuing operations and raised its full-year revenue growth outlook, citing record bookings, expanding customer relationships and increased demand for ruggedized artificial intelligence and high-performance com
BDX's Medical Essentials and Interventional strength may drive third-quarter fiscal 2026 results, but China, vaccines and projected declines weigh on expectations.
Arc, Circle's institutional blockchain, goes live September 16th with a validator cohort built from TradFi giants.
Billionaire investor Mark Cuban turned to AI chatbot Grok on Monday to test the economics behind New York City Mayor Zohran Mamdani‘s proposal for city-owned grocery stores, asking whether the concept could break even after estimating store margins and operating...
Financial stocks were advancing in Wednesday afternoon trading, with the NYSE Financial Index rising
Can FIX sustain industry-leading margins through disciplined bidding, strong demand and its record backlog?
The Cosmos EV is now slated for release in the second half of 2027. CEO Silivo Napoli said he's focused on getting the EV right as well as its nearer-term robotaxi project with Uber and Nuro.
(Bloomberg) -- Ares Management Corp. is leading a $2.2 billion direct loan to help finance a healthcare services acquisition, in one of the biggest deals since the private credit market was roiled by record redemptions this year.Most Read from BloombergSpaceX’s AI Splurge Puts a Damper on First Earnings After IPOTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallBe
Catalyst's Q2 earnings per share are strained by merger costs and loan declines, but higher net interest income, improving credit quality and deposit growth support results.
GSIT's Q1 loss per share widened year over year due to margin pressure and higher R&D spending, while steady SRAM demand and Gemini-II commercialization progress provided support.
Energy stocks were lower Wednesday afternoon, with the NYSE Energy Sector Index falling 1.7% and the
SpaceX reported its first quarterly results as a public company, beating on revenue but falling 11% as investors focused on heavy capital spending. Its 18,712 bitcoin lost roughly $195 million in value during the quarter. CoinDesk's Jennifer Sanasie hosts "CoinDesk Daily."
Stocks took a turn lower, reversing earlier gains in midday trading. The Nasdaq Composite fell 0.5%, while the S&P 500 was roughly flat after opening the session higher. The Dow Jones Industrial Average was up 0.
Lumentum shares are already up about 130% in 2026, while strong earnings growth and a $1,100 analyst target suggest Wall Street sees further upside.
SpaceX stock has been weak for weeks. Analysts are sticking with their price targets. The average analyst price target for SpaceX stock is about $227 a share, according to FactSet, down $1 since SpaceX reported better-than-expected second-quarter numbers on Tuesday evening.
More capable AI could create multiple different profit opportunities.
CEO Stephen Yalof said Tanger centers in 8 of 11 host cities saw gains from international visitors, with sales up about 5% for the year
Chip stocks may be primed for a rebound as AI spending stays strong, technical signals improve and Wall Street sees the recent semiconductor selloff easing.
Big Tech just closed out its second-quarter 2026 earnings season, and the results looked, on paper, like a triumph. Microsoft, Amazon, and Alphabet all posted numbers that blew past Wall Street's estimates, and headlines celebrated growth rates that haven't been seen in years. Dig one layer deeper, ...
Micron, Samsung and SK Hynix have reportedly committed significant portions of their 2027 output.
📣"I don't know the needs of the two competitors that are right now trying to talk to each other, but we don't see a need for a transformative M&A right now." —Mike Doustdar, CEO of Ozempic maker Novo Nordisk in an interview with the Journal, referring to a recent Financial Times report that AstraZeneca and Bristol Myers Squibb held talks over a tie-up.
RGTI joins HPE and PSC on a $5 million NSF-backed hybrid quantum-classical testbed set to begin construction in September 2026.
NKE's performance-led strategy centers on innovation, athlete engagement and sport-focused execution to drive long-term growth despite near-term demand challenges.
Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index rising 1.1% and th
Leidos Holdings' (LDOS) diversified portfolio remains underappreciated, with strength in its Homelan
TransDigm's (TDG) stock decline following strong fiscal Q3 results was surprising, but investors are
TransMedics stock slipped on mixed results, but its future remains bright.
Networking stocks surge as Trump drafts a ban on a vital Chinese data center component.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
